Pharma News

In a significant development, Bharat Biotech has sought Drug Controller General India's (DCGI) approval to conduct nasal COVID-19 vaccine trials in India. The company has developed a new single-dose nasal COVID-19 vaccine in a partnership with Washington University in St Louis, USA. There are no intra-nasal COVID-19 vaccines under trial in India at the moment.

There is currently no cure for osteoarthritis, but a group of scientists believe they've discovered a method through which a simple knee injection could potentially stop the disease's effects. These researchers showed that they could target a specific protein pathway in mice, put it into overdrive and halt cartilage degeneration over time.

One reason it’s so difficult to produce effective vaccines against some viruses, including influenza and HIV, is that these viruses mutate very rapidly. This allows them to evade the antibodies generated by a particular vaccine, through a process known as “viral escape.”

India has vaccinated the highest number of persons on Day1 under its COVID19 vaccination program, the world’s largest such exercise. This is much higher than many other countries such as the USA, the UK and France.

Total of 2,24,301 beneficiaries have been vaccinated till today as per the provisional report.

A new Northwestern University-led study is unfolding the mystery of how RNA molecules fold themselves to fit inside cells and perform specific functions. The findings could potentially break down a barrier to understanding and developing treatments for RNA-related diseases, including spinal muscular atrophy and perhaps even the novel coronavirus.

Scientists studying the body’s natural defenses against bacterial infection have identified a nutrient taurine that helps the gut recall prior infections and kill invading bacteria, such as Klebsiella pneumoniae (Kpn). The finding, published in the journal Cell by scientists from five institutes of the National Institutes of Health, could aid efforts seeking alternatives to antibiotics.

Today marks a momentous day in the COVID-19 trajectory of the country as India rolls out the world’s largest COVID-19 vaccination drive today. Hon. Prime Minister will launch the nationwide vaccination exercise at 10.30 am through video conference.

This day also sees India’s total Active Caseload (2,11,033) further slump to account for just 2% of the total positive cases. The active cases were 2,10,120 last on 29th June 2021.

The Total Recoveries have crossed 96% of the total cases, at 96.56%.

Sanofi and Kymab, a clinical-stage biopharmaceutical company developing fully human monoclonal antibodies with a focus on immune-mediated diseases and immuno-oncology therapeutics, have entered into an agreement under which Sanofi will acquire Kymab for an upfront payment of approximately USD 1.1 billion and up to 350 million upon achievement of certain milestones.

Airborne transmission of the novel coronavirus is possible under certain conditions, cautions a study undertaken by the Centre for Cellular and Molecular Biology (CCMB). The research was conducted to determine the transmission pattern of the virus in various enclosures in hospitals to assess the risks posed to healthcare workers. Air samples were collected from hospitals in Hyderabad and Mohali for the study.